CMBA
LEGN icon

C.M. Bidwell & Associates’s Legend Biotech LEGN Stock Holding History

C.M. Bidwell & Associates’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,110
Closed -$56K – 597
2021
Q3 		$56K Sell
1,110
-45
-4% -$1.87K 0.04% 291
2021
Q2 		$47K Buy
+1,155
New +$39.3K 0.03% 305

Other funds holding LEGN

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

C.M. Bidwell & Associates's LEGN Position: Q4 2021 in Review

C.M. Bidwell & Associates sold out of Legend Biotech (LEGN) in Q4 2021, closing a stake of 1,110 shares — an estimated $56K sold.

C.M. Bidwell & Associates first reported a position in LEGN in Q2 2021 and held it in 2 quarters. The position peaked at $56K in Q3 2021. 139 funds tracked by Wall St. Rank hold LEGN as of Q4 2021.

  • C.M. Bidwell & Associates reported no remaining Legend Biotech position as of Q4 2021 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 1,110 Legend Biotech shares in Q4 2021, an estimated $56K.
  • C.M. Bidwell & Associates first reported a position in Legend Biotech in Q2 2021 and held it in 2 quarters.
  • C.M. Bidwell & Associates's Legend Biotech position peaked at $56K in Q3 2021.
  • 139 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2021.

Based on C.M. Bidwell & Associates's 13F filing for Q4 2021, filed 11 Feb 2022.